Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) — Cash Flow Reinvestment Rate
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) has a Cash Flow Reinvestment Rate of 0.29x as of March 2023, reinvesting €54.13 Million (capex €44.48 Million plus investments €9.65 Million) from operating cash flow of €186.97 Million. See Tianjin Zhong Xin Pharmaceutical Group C free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited across 12 annual periods. For the full cash flow conversion analysis, see how efficiently does Tianjin Zhong Xin Pharmaceutical Group C generate cash.
Annual Cash Flow Reinvestment Rate for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2013–2025)
Year-by-year capital reinvestment analysis for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited. See financial flexibility index of Tianjin Zhong Xin Pharmaceutical Group C to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.05x | €1.41 Billion | €461.07 Million | €118.61 Million | ▲ +205.1% |
| 2024 | 1.00x | €925.65 Million | €924.67 Million | €117.81 Million | ▼ -2.9% |
| 2023 | 1.03x | €709.84 Million | €688.49 Million | €140.93 Million | ▲ +481.0% |
| 2022 | 0.18x | €120.18 Million | €677.25 Million | €107.90 Million | ▼ -69.2% |
| 2021 | 0.58x | €491.87 Million | €852.40 Million | €156.95 Million | ▲ +68.3% |
| 2020 | 0.34x | €230.21 Million | €671.42 Million | €189.16 Million | ▼ -44.1% |
| 2019 | 0.61x | €303.67 Million | €495.49 Million | €205.61 Million | ▼ -62.9% |
| 2018 | 1.65x | €578.87 Million | €350.14 Million | €175.81 Million | ▲ +237.4% |
| 2016 | 0.49x | €204.73 Million | €417.77 Million | €116.20 Million | ▼ -61.4% |
| 2015 | 1.27x | €457.26 Million | €360.58 Million | €92.64 Million | ▲ +116.0% |
| 2014 | 0.59x | €168.37 Million | €286.85 Million | €70.15 Million | ▼ -63.7% |
| 2013 | 1.61x | €344.69 Million | €213.44 Million | €72.42 Million | — |